marketcaparena
Search

    CTOR

    CITIUS ONCOLOGY, INC.

    Company overview

    Market capitalization
    $95.77M
    Employees
    0
    Latest publication
    2026-09-29
    About CITIUS ONCOLOGY, INC.

    Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. is a subsidiary of Leonard-Meron Biosciences, Inc.

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ3 20262026-06-30 · USDQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USD
    Total Revenue1,493,788USD1,667,298USD3,944,111USD———0USD—
    Cost Of Revenue491,843USD328,878USD789,208USD———0USD—
    Gross Profit1,001,945USD1,338,420USD3,154,903USD———0USD—
    Research Development218,496USD1,079,354USD1,018,352USD73,400,000USD938,277,000,000USD3,139,413,000,000USD1,264,508USD73,400,000,000,000USD
    Selling General Administrative4,219,163USD23,625,639USD2,859,339USD———5,130,457USD—
    General And Administrative Expenses4,219,163USD23,625,639USD2,859,339USD—————
    Total Operating Expenses9,718,762USD29,952,015USD8,407,179USD23,522,750USD4,944,961,000,000USD7,471,312,000,000USD6,394,965USD20,572,747,000,000USD
    Operating Income-8,716,817USD-28,613,595USD-5,252,276USD———-6,394,965USD—
    Total Other Income Expense Net-314,376USD1,772,690USD-17,553USD———-6,394,965USD—
    Interest Income96,848USD43,721USD28,288USD———0USD—
    Interest Expense231,732USD33,031USD45,841USD———0USD—
    Income Before Tax-9,031,193USD-26,840,905USD-5,269,829USD———-6,394,965USD—
    Income Tax Expense-107,347USD-231,210USD264,240USD1,056,960USD264,240,000,000USD264,240,000,000USD264,240USD576,000,000,000USD
    Net Income-8,923,846USD-26,609,695USD-5,534,069USD-24,761,369USD-5,369,956,000,000USD-7,735,552,000,000USD-6,659,205USD-21,148,747,000,000USD
    Net Interest Income——————0USD—
    Tax Provision——————264,240USD—
    Net Income From Continuing Ops——————-6,659,205USD—
    Ebit——————-6,394,965USD—
    Ebitda——————-6,394,965USD—
    Reconciled Depreciation——————0USD—
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosurePreliminaryDisclosurePreliminaryDisclosurePreliminaryLegacy providerLegacyDisclosurePreliminary

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USD
    Total Revenue0USD0USD0USD0USD—
    Research Development6,418,334USD4,925,000USD4,240,451USD6,855,718USD—
    Selling General Administrative17,104,416USD15,647,746USD7,880,790USD2,857,480USD—
    Total Operating Expenses23,522,750USD20,572,747USD12,121,241USD9,713,198USD—
    Operating Income-23,522,750USD-20,572,747USD-12,121,241USD-9,713,198USD—
    Interest Income36,373USD0USD———
    Interest Expense218,032USD0USD———
    Net Interest Income-181,659USD0USD———
    Income Before Tax-23,704,409USD-20,572,747USD-12,121,241USD-9,713,198USD-10,113USD
    Income Tax Expense1,056,960USD576,000USD576,000USD1,152,000USD—
    Tax Provision1,056,960USD576,000USD576,000USD576,000USD—
    Net Income-24,761,369USD-21,148,747USD-12,697,241USD-10,865,198USD-10,113USD
    Net Income From Continuing Ops-24,761,369USD-21,148,747USD-12,697,241USD-5,432,599USD—
    Ebitda-23,486,377USD-20,572,747USD-12,121,241USD-4,856,599USD-10,110USD
    Total Other Income Expense Net-181,659USD———-10,113USD
    Ebit—-20,572,747USD-12,121,241USD-4,856,599USD—
    Depreciation And Amortization———9,713,198USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ3 20262026-06-30 · USDQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USD
    Total Assets112,093,103USD100,699,168USD109,973,406USD100,942,881USD91,709,079USD91,439,365USD90,481,481USD84,368,878USD
    Cash And Equivalents16,563,705USD2,632,634USD7,295,451USD—112USD112USD——
    Total Current Assets42,707,165USD29,423,666USD37,146,844USD27,542,881USD18,309,079USD18,039,365USD17,081,481USD10,968,878USD
    Total Liabilities71,708,109USD65,430,399USD51,559,705USD56,076,650USD59,311,166USD55,796,733USD49,191,869USD38,228,540USD
    Total Current Liabilities58,787,194USD58,812,298USD44,710,394USD49,491,579USD52,990,335USD49,740,142USD43,399,518USD32,700,429USD
    Other Current Liabilities25,836,120USD24,057,573USD4,518,916USD4,093,124USD8,458,554USD8,722,168USD6,228,612USD—
    Total Stockholder Equity40,384,994USD35,268,769USD58,413,701USD44,866,231USD32,397,913USD35,642,632USD41,289,612USD46,140,339USD
    Total Equity Including Noncontrolling Interest40,384,994USD35,268,769USD58,413,701USD44,866,231USD32,397,913USD35,642,632USD41,289,612USD46,140,338USD
    Net Receivables686,235USD1,079,055USD4,049,111USD—————
    Inventory22,625,945USD22,659,590USD22,639,342USD22,286,693USD17,208,967USD15,339,253USD14,381,369USD8,268,766USD
    Accounts Payable7,315,516USD8,883,239USD10,446,900USD13,234,684USD8,667,419USD7,676,310USD5,874,577USD3,711,622USD
    Common Stock10,576USD9,298USD8,480USD8,351USD7,155USD7,155USD7,155USD7,155USD
    Retained Earnings-105,107,566USD-96,183,720USD-69,574,025USD-64,039,956USD-59,043,300USD-53,673,344USD-45,937,792USD-39,278,587USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinal

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USD
    Total Assets100,942,881USD84,368,878USD47,734,895USD42,690,182USD—
    Total Current Assets27,542,881USD10,968,878USD7,734,895USD2,690,182USD—
    Total Liabilities56,076,650USD38,228,540USD———
    Total Current Liabilities49,491,579USD32,700,429USD21,047,235USD5,846,781USD—
    Other Current Liabilities4,093,124USD————
    Total Stockholder Equity44,866,231USD46,140,339USD25,535,660USD36,267,401USD—
    Total Equity Including Noncontrolling Interest44,866,231USD46,140,338USD———
    Inventory22,286,693USD8,268,766USD0USD——
    Accounts Payable13,234,684USD3,711,622USD1,289,045USD92,311USD—
    Common Stock8,351USD7,155USD6,750USD6,750USD—
    Retained Earnings-64,039,956USD-39,278,587USD-18,129,840USD-5,432,599USD—
    Intangible Assets——40,000,000USD40,000,000USD—
    Other Current Assets——7,734,895USD2,690,182USD—
    Total Liab——22,199,235USD6,422,781USD—
    Other Current Liab——19,758,190USD5,754,470USD—
    Capital Stock——6,750USD6,750USD—
    Cash——26,523USD289,175USD—
    Net Debt——-26,523USD-289,175USD—
    Common Stock Shares Outstanding——89,479,860shares90,160,000shares81,400,000shares
    Non Current Assets Total——40,000,000USD40,000,000USD—
    Non Current Liabilities Total——1,152,000USD576,000USD—
    Non Currrent Assets Other——40,000,000USD40,000,000USD—
    Net Working Capital——-13,312,340USD-3,156,599USD—
    Unclassified Non Current Assets——-40,000,000USD-40,000,000USD—
    Unclassified Non Current Liabilities——1,152,000USD——
    Unclassified Equity——43,652,000USD41,686,500USD—
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ3 20262026-06-30 · USDQ2 20262026-03-31 · USD
    Stock Based Compensation11,043,551USD7,482,760USD
    Deferred Income Tax-74,317USD33,030USD
    Change To Account Receivables-686,235USD-1,079,055USD
    Change To Inventory-339,252USD-372,897USD
    Change To Liabilities19,980,496USD19,964,449USD
    Change In Working Capital-1,025,487USD-1,451,952USD
    Operating Cash Flow-13,897,194USD-11,186,564USD
    Investing Cash Flow-7,000,000USD-5,000,000USD
    Financing Cash Flow33,535,991USD14,894,290USD
    Change In Cash12,638,797USD-1,292,274USD
    End Cash Flow16,563,705USD2,632,634USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ3 20262026-06-30 · USDQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USD
    Net Income-8,923,846USD-26,609,695USD—-24,761,369USD-5,369,956USD-7,735,552USD-6,659,205USD-21,148,747,000,000USD
    Stock Based Compensation3,560,791USD3,526,710USD3,956,050USD8,320,419USD2,125USD2,088USD1,808,478USD7,498,817,000,000USD
    Investing Cash Flow-7,000,000USD-5,000,000USD-4,400,000USD-5,750,000USD———-5,000,000,000,000USD
    Financing Cash Flow33,535,991USD14,894,290USD15,125,489USD15,166,842USD———4,873,759,000,000USD
    Change In Cash12,638,797USD-1,292,274USD3,370,543USD3,924,796USD0USD0USD-32,633USD112,000,000USD
    End Cash Flow16,563,705USD2,632,634USD7,295,451USD—————
    Deferred Income Tax——264,240USD—————
    Change To Account Receivables——-4,049,111USD——0USD0USD—
    Change To Inventory——-352,649USD—-1,910,519USD-914,680USD-6,112,603USD—
    Change To Liabilities——425,792USD—————
    Change In Working Capital——-4,401,760USD—3,037,922USD5,321,823USD4,586,487USD—
    Operating Cash Flow——-7,354,946USD————126,353,000,000USD
    Other Non Cash Items————2,064,778USD2,152,719USD1,808,479USD—
    Total Cash From Operating Activities————0USD0USD0USD—
    Capital Expenditures————0USD0USD0USD—
    Free Cash Flow————0USD0USD0USD—
    Begin Period Cash Flow————112USD112USD32,745USD—
    End Period Cash Flow————112USD112USD112USD—
    Depreciation—————0USD0USD—
    Total Cash From Financing Activities—————0USD0USD—
    Issuance Of Capital Stock—————0USD0USD—
    Unclassified Operating Cash Flow——————-1,544,239USD—
    SourceDisclosurePreliminaryDisclosurePreliminaryDisclosureDeterministicFinalDisclosurePreliminaryLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyDisclosurePreliminary

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USD
    Stock Based Compensation8,320,419USD7,498,817USD1,965,500USD0USD
    Deferred Income Tax1,056,960USD576,000USD——
    Change To Inventory-12,649,207USD-2,133,871USD0USD—
    Change To Liabilities4,093,124USD-259,071USD——
    Change In Working Capital-12,649,207USD-2,133,871USD411,766USD64,241USD
    Operating Cash Flow-5,492,046USD126,353USD——
    Investing Cash Flow-5,750,000USD-5,000,000USD——
    Financing Cash Flow15,166,842USD4,873,759USD——
    Change In Cash3,924,796USD112USD-256,430USD289,175USD
    End Cash Flow3,924,908USD112USD——
    Net Income——2,419,304USD380,811USD
    Other Non Cash Items——-3,432,374USD-493,020USD
    Change To Account Receivables——349,051USD25,988USD
    Total Cash From Operating Activities——-601,304USD-47,968USD
    Capital Expenditures——-4USD0USD
    Free Cash Flow——-601,300USD-47,970USD
    Investments——0USD—
    Total Cashflows From Investing Activities——-1,320,000USD-67,320,000USD
    Net Borrowings——0USD—
    Total Cash From Financing Activities——1,664,875USD67,657,143USD
    Begin Period Cash Flow——289,175USD0USD
    End Period Cash Flow——32,745USD289,175USD
    Other Cashflows From Financing Activities——1,664,875USD-383,844USD
    Unclassified Operating Cash Flow——-1,965,500USD—
    Unclassified Investing Cash Flow——-1,319,996USD-67,320,000USD
    Unclassified Financing Cash Flow———68,040,987USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.